Instrument Inactif

Communiqués Cannabis Science Inc OTC Bulletin Board

Actions

US1376481016

Recherche biotechnologique et médicale

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

05/08/24	Strainsforpains, Inc. signe un accord international de commercialisation au détail et en gros de médicaments cannabinoïdes avec Cannabis Science, Inc.	CI
21/04/23	GBX International Group Inc. accepte de se séparer de Cannabis Science, Inc.	CI

Communiqués

06/09/19	Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements	GL
28/08/19	Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions	GL
15/08/19	Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally	GL
05/08/19	Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations	GL
26/07/19	Cannabis Science, Inc. Successfully Completes Lab Testing for Its Proprietary, Short-Time Vacuum Distillation Process for Distribution of Purified High CBDA and CBD Water-Soluble Powders and Extracts Internationally	GL
08/07/19	Mr. Raymond C. Dabney Prepares Cannabis Science for the Next Level With Key Acquisitions Negotiated and Planned Mergers, a New Branding Splash, and a Black-Tie Dinner Awards Gala for the Ages	GL
03/06/19	Cannabis Science Propels Cancer Clinical Trials, Appoints Cellular Cancer Specialist Dr. Sulma Mohammed, Professor of Cancer Biology, Purdue University, to the Company’s Scientific Advisory Board	GL
31/05/19	GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School	GL
20/05/19	Cannabis Science and Dana-Farber Cancer Institute Sign a New Research Agreement to Investigate Proprietary Extract From Justicia Plant	GL
10/05/19	Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials; Right on Time for the Upcoming Global Health Catalyst Summit at Harvard Medical School, May 24-26, 2019	GL
25/03/19	Cannabis Science Expands Into Canadian Market With Wholly-Owned Subsidiary Cannabis Science Canada Inc., Commences Negotiations for Canadian Land, Licenses, and Expansion Capital	GL
15/03/19	Cannabis Science iCannabinoid Ambassadors Program Appointments Underway; Ambassadors Will Promote Company Initiatives Globally and Help Share Accurate and Reliable Health Information	GL
25/02/19	Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include Its U.S. Patent Number 9,763,991 for Compositions of Cannabinol (CBN) for Treatment of Various Neurological Conditions	GL
08/02/19	Cannabis Science Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift; Planning Underway for the Company’s 2019 Black-Tie Dinner Awards Gala Presentations	GL
23/01/19	Overwhelming CBIS Shareholder Responses Prompts RCD to Choose www.iCannabinoid.com to Interact and Inform on All Company Projects, Drug Development, and All RCD Initiatives	GL
14/01/19	Cannabis Science Receives Overwhelming Response From Mr. Raymond C. Dabney’s Shareholder Loyalty Gift Package; Get Set for Cannabis Science 2019 Black-Tie Dinner Awards Gala	GL
24/12/18	CBIS Celebrates U.S. Congress Passage of the 2018 Farm Bill and RCD Welcomes All Shareholders to the Loyalty Gift Final	GL
21/11/18	The Cannabis Science Inaugural Black-Tie Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty	GL
21/11/18	The Cannabis Science Inaugural Black-Tie Dinner Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty	GL
29/10/18	Cannabis Science Confirms Receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and (PTSD)	GL
24/10/18	CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr. Foote Will Continue to Counsel CBIS as South African Cannabinoid Clinical Studies are Underway	GL
01/10/18	UPDATE: Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board (IGAB)	GL
28/09/18	Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board	GL
26/09/18	Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board	GL
21/09/18	Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board	GL